Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Judge Won’t Dismiss J & J Lawsuit Linking Cancer to Talc

By Pharmaceutical Processing | September 23, 2010

SIOUX FALLS, S.D. (AP) — A federal judge has refused to dismiss a lawsuit
alleging a woman’s use of Johnson & Johnson products that contained talcum
caused ovarian cancer, saying the suit was filed on the last allowable day.

U.S. District Judge Karen Schreier denied a motion by the company and other
defendants, including mining company Luzenac America Inc., that claimed the suit
was filed after the statute of limitations. Talc is a mined mineral that is used
in talcum power.

The complaint alleges that research from 1988 to 1992 found that frequent
application of talc-based powder in the genital area increases the risk of
ovarian cancer. Johnson & Johnson failed to inform consumers of the risk as
it promoted female use of talc-based products such as Shower to Shower and
Johnson’s Baby Powder, according to the lawsuit.

The lawsuit was filed by Sioux Falls resident Deane Berg, who was diagnosed
with ovarian cancer in 2006. The lawsuit claims she used talcum-based products
for hygiene purposes for about 30 years.

“This was an intended and foreseeable use of the defendants’ products based
on the advertising, marketing and labeling of the products by the defendants,”
the lawsuit said.

The American Cancer Society said studies of personal use of talcum powder and
ovarian cancer have yielded inconsistent results.

“Findings are mixed, with some studies reporting a slightly increased risk
and some reporting no association,” the organization said on its website. “Only
a small minority of women who have used talcum powder will ever develop ovarian
cancer and it is impossible to say to what extent talc use had contributed to
these cases.”

Berg’s attorney, R. Allen Smith Jr., did not return a message for comment
Wednesday. He is affiliated with the Mississippi-based Talc Litigation Group,
which claims on its website that the lawsuit is the first involving talc use and
ovarian cancer.

Johnson & Johnson has not filed a formal answer to the lawsuit. Phone and
e-mail messages to its attorneys were not returned Wednesday. Luzenac said it
can’t be held liable because it supplied a bulk raw material that met all safety
standards when provided to a manufacturer. The judge earlier dismissed Luzenac
America’s parent company as a defendant.

The suit also names unidentified individuals and corporations as
defendants.

Schreier ruled that the applicable three-year statute of limitations on suing
began with Berg’s cancer diagnosis on Dec. 26, 2006. The defendants said the
deadline expired because the lawsuit effectively began when affidavits
acknowledging they had been notified of the lawsuit were filed in court on Jan.
4, 2010.

But the judge said the lawsuit began when defendants acknowledged on Dec. 27,
2009 and Dec. 28, 2009 that they were being sued. That was within the three-year
period since Dec. 26, 2009, fell on a Saturday so the deadline effectively was
Monday, Dec. 28, Schreier said.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE